Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa00190 | Oxidative phosphorylation | 33/794 | 134/8135 | 0.000000379 | 0.0000303 | 0.0000237 | 33 | RABC65 | |
| KEGG | hsa05208 | Chemical carcinogenesis - reactive oxygen species | 44/794 | 223/8135 | 0.00000365 | 0.0002002 | 0.0001567 | 44 | RABC65 | |
| KEGG | hsa05169 | Epstein-Barr virus infection | 41/794 | 202/8135 | 0.00000375 | 0.0002002 | 0.0001567 | 41 | RABC65 | |
| KEGG | hsa04658 | Th1 and Th2 cell differentiation | 24/794 | 92/8135 | 0.00000504 | 0.0002304 | 0.0001804 | 24 | RABC65 | |
| KEGG | hsa04659 | Th17 cell differentiation | 26/794 | 108/8135 | 0.0000101 | 0.0004046 | 0.0003168 | 26 | RABC65 | |
| KEGG | hsa05016 | Huntington disease | 53/794 | 306/8135 | 0.0000209 | 0.0007415 | 0.0005805 | 53 | RABC65 | |
| KEGG | hsa05020 | Prion disease | 48/794 | 273/8135 | 0.0000345 | 0.001027 | 0.0008044 | 48 | RABC65 | |
| KEGG | hsa05340 | Primary immunodeficiency | 13/794 | 38/8135 | 0.0000353 | 0.001027 | 0.0008044 | 13 | RABC65 | |
| KEGG | hsa04623 | Cytosolic DNA-sensing pathway | 17/794 | 63/8135 | 0.0000753 | 0.002009 | 0.001572 | 17 | RABC65 | |
| KEGG | hsa05022 | Pathways of neurodegeneration - multiple diseases | 72/794 | 476/8135 | 0.0000856 | 0.002106 | 0.001649 | 72 | RABC65 | |
| KEGG | hsa04510 | Focal adhesion | 37/794 | 201/8135 | 0.0001024 | 0.00234 | 0.001832 | 37 | RABC65 | |
| KEGG | hsa04714 | Thermogenesis | 41/794 | 232/8135 | 0.0001135 | 0.002422 | 0.001896 | 41 | RABC65 | |
| KEGG | hsa05010 | Alzheimer disease | 60/794 | 384/8135 | 0.0001367 | 0.002673 | 0.002092 | 60 | RABC65 | |
| KEGG | hsa05416 | Viral myocarditis | 16/794 | 60/8135 | 0.000142 | 0.002673 | 0.002092 | 16 | RABC65 | |
| KEGG | hsa00071 | Fatty acid degradation | 13/794 | 43/8135 | 0.0001504 | 0.002674 | 0.002093 | 13 | RABC65 | |
| KEGG | hsa04640 | Hematopoietic cell lineage | 22/794 | 99/8135 | 0.0001716 | 0.002889 | 0.002262 | 22 | RABC65 | |
| KEGG | hsa04723 | Retrograde endocannabinoid signaling | 29/794 | 148/8135 | 0.000187 | 0.002992 | 0.002342 | 29 | RABC65 | |
| KEGG | hsa04662 | B cell receptor signaling pathway | 19/794 | 82/8135 | 0.0002651 | 0.00404 | 0.003163 | 19 | RABC65 | |
| KEGG | hsa05145 | Toxoplasmosis | 23/794 | 112/8135 | 0.0004205 | 0.006116 | 0.004788 | 23 | RABC65 | |
| KEGG | hsa05014 | Amyotrophic lateral sclerosis | 55/794 | 364/8135 | 0.0006062 | 0.008434 | 0.006603 | 55 | RABC65 | |
| KEGG | hsa04611 | Platelet activation | 24/794 | 124/8135 | 0.0007854 | 0.01013 | 0.007933 | 24 | RABC65 | |
| KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 19/794 | 89/8135 | 0.0007916 | 0.01013 | 0.007933 | 19 | RABC65 | |
| KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 88/2153 | 222/8135 | 0.00000987 | 0.002743 | 0.002187 | 88 | RABC66 | |
| KEGG | hsa04350 | TGF-beta signaling pathway | 44/2153 | 94/8135 | 0.0000164 | 0.002743 | 0.002187 | 44 | RABC66 | |
| KEGG | hsa05169 | Epstein-Barr virus infection | 79/2153 | 202/8135 | 0.0000484 | 0.005386 | 0.004295 | 79 | RABC66 | |
| KEGG | hsa05416 | Viral myocarditis | 30/2153 | 60/8135 | 0.0000794 | 0.006633 | 0.005289 | 30 | RABC66 | |
| KEGG | hsa05225 | Hepatocellular carcinoma | 66/2153 | 168/8135 | 0.0001691 | 0.0113 | 0.009009 | 66 | RABC66 | |
| KEGG | hsa04390 | Hippo signaling pathway | 62/2153 | 157/8135 | 0.0002224 | 0.01238 | 0.009871 | 62 | RABC66 | |
| KEGG | hsa05205 | Proteoglycans in cancer | 76/2153 | 205/8135 | 0.0004775 | 0.02278 | 0.01817 | 76 | RABC66 | |
| KEGG | hsa04144 | Endocytosis | 90/2153 | 251/8135 | 0.0005535 | 0.02311 | 0.01843 | 90 | RABC66 |